Neonatal Thrombosis (Arterial & Venous / RVT)

Risk Factors & Pathogenesis

• Neonatal hemostasis is uniquely balanced ('developmental hemostasis' - low levels of BOTH procoagulants like Factor II/X and anticoagulants like Protein C/S/Antithrombin).
• Vascular catheters (UVC, UAC, PICC) are responsible for >80% of all neonatal thrombotic events.
• Additional precise risk factors: Polycythemia, severe dehydration, maternal diabetes (IDM), perinatal asphyxia.
• Renal Vein Thrombosis (RVT): Classic presentation in neonates. Triad of macroscopic hematuria, palpable unilateral/bilateral flank mass, and severe consumptive thrombocytopenia (platelets trapped in massive clot).

Diagnostic Imaging Protocol

• Gold Standard: Targeted Doppler Ultrasound (cranial, abdominal, or extremity depending on catheter site or symptoms).
• Echocardiogram: Mandatory for suspected Right Atrial thrombosis related to terminal positioning of UVCs or central lines.
• Aortic Thrombosis (UAC complication): Presents with sudden loss of femoral/pedal pulses, profound lower extremity blanching or cyanosis ('blue toes' or line demarcations). Remove UAC immediately.

Anticoagulation & Thrombolysis (Dosing Guidelines)

• Low Molecular Weight Heparin (LMWH) - Enoxaparin: Drug of choice. Due to rapid neonatal clearance and increased volume of distribution, neonates require higher doses than adults. Dose: 1.5 - 1.7 mg/kg SQ every 12 hours (for infants < 2 months).
• Monitoring Enoxaparin: Measure Anti-Xa levels 4 hours post-dose. Target therapeutic range: 0.5 to 1.0 Units/mL.
• Unfractionated Heparin (UFH): Used for highly unstable patients or anticipated surgery due to rapid reversibility. Loading dose 75 Units/kg, maintenance 20-28 Units/kg/hr. Target anti-Xa 0.35-0.7 U/mL.
• Thrombolysis (Alteplase / tPA): EXTREME RISK (Brain Hemorrhage). Reserved absolutely for life-, limb-, or organ-threatening massive arterial thrombosis unresponsive to heparin. Dosed precisely via infusion (0.1 to 0.5 mg/kg/hr); strictly monitor fibrinogen.
• Before tPA, always perform Head Ultrasound to rule out pre-existing IVH.

Diagnostic & Management Algorithm

• Arterial/Venous Clot Algorithm: [START] Line-associated Thrombus detected -> [DECISION] Life/limb threatening? -> [YES] Consideration for tPA / Surgical thrombectomy -> [NO] Enoxaparin (LMWH) / UFH anticoagulation

References

1. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.